How Big Pharma games the system — and keeps drug

Layers of market protections and courtroom tricks keep competitors off the market far longer than rules intended, say generics firms.

Related Keywords

Italy , United States , Germany , Poland , Borrat , Baden Wüberg , American , , Amgen , European Commission , A European Parliament , European Consumer Organisation , European Patent Office , European Medicines Agency , Europe Patent Office , Big Pharma , Patent Office , European Patent , European Parliament , Eastern European , Adrian Van Den Hoven , Business And Competition , Companies , Courts , Drug And Device Safety , Eu27 , Generics And Biosimilars , Genetics , Innovation , Manufacturing , Medicines , Patents , Patients , Personalized Medicines , Pharma , Public Health , Rare Diseases , Regulation ,